Association between Adverse Reactions to the First and Second Doses of COVID-19 Vaccine

被引:6
作者
Goda, Ken [1 ,2 ]
Kenzaka, Tsuneaki [1 ,2 ]
Yahata, Shinsuke [3 ]
Okayama, Masanobu [4 ]
Nishisaki, Hogara [1 ]
机构
[1] Hyogo Prefectural Tamba Med Ctr, Dept Internal Med, Tamba 6693495, Japan
[2] Kobe Univ, Div Community Med & Career Dev, Grad Sch Med, 2-1-5 Arata Cho, Kobe, Hyogo 6520032, Japan
[3] Hyogo Prefectural HarimaHimeji Gen Med Ctr, Dept Gen Internal Med, 3-264 Kamiya Cho, Himeji 6708560, Japan
[4] Kobe Univ, Div Community Med & Med Educ, Grad Sch Med, 2-1-5 Arata Cho, Kobe, Hyogo 6520032, Japan
关键词
COVID-19; vaccine; adverse reactions; first dose; second dose; SAFETY;
D O I
10.3390/vaccines10081232
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study investigated the frequency of adverse reactions to COVID-19 vaccines in Japan and the impact of first-dose adverse reactions on second-dose adverse reactions. Individuals who received an mRNA COVID-19 vaccine at our center in March or April 2021 were included. Data were collected using questionnaires. The main factors were age (<40, 40-59, and >60 years), sex, underlying disease, and first-dose adverse reaction. The primary outcomes were incidence of local and systemic adverse reactions (ARs) attributable to the vaccine. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Among 671 participants, 90% experienced local or systemic ARs. An AR to the first dose was associated with a significantly increased risk of an AR to the second dose (OR: 49.63, 95% CI: 21.96-112.16). ARs were less common among men than among women (OR: 0.36, 95% CI: 0.17-0.76). Local ARs were less common among those aged 60 years or older (OR: 0.35, 95% CI: 0.18-0.66), whereas systemic ARs were more common among those aged under 40 years. Information on ARs to the first dose is important for healthcare providers and recipients when making vaccination decisions.
引用
收藏
页数:11
相关论文
共 21 条
[1]   Brief report: attitudes towards Covid-19 vaccination among hospital employees in a tertiary care university hospital in Germany in December 2020 [J].
Bauernfeind, Stilla ;
Hitzenbichler, Florian ;
Huppertz, Gunnar ;
Zeman, Florian ;
Koller, Michael ;
Schmidt, Barbara ;
Plentz, Annelie ;
Bauswein, Markus ;
Mohr, Arno ;
Salzberger, Bernd .
INFECTION, 2021, 49 (06) :1307-1311
[2]   Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions [J].
Bunders, Madeleine J. ;
Altfeld, Marcus .
IMMUNITY, 2020, 53 (03) :487-495
[3]   Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial [J].
Cadorna-Carlos, Josefina B. ;
Nolan, Terry ;
Borja-Tabora, Charissa Fay ;
Santos, Jaime ;
Montalban, M. Cecilia ;
de Looze, Ferdinandus J. ;
Eizenberg, Peter ;
Hall, Stephen ;
Dupuy, Martin ;
Hutagalung, Yanee ;
Pepin, Stephanie ;
Saville, Melanie .
VACCINE, 2015, 33 (21) :2485-2492
[4]  
Centres for Disease Control and Prevention, REACT ADV EV PFIZ BI
[5]   Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study [J].
El-Shitany, Nagla A. ;
Harakeh, Steve ;
Badr-Eldin, Shaimaa M. ;
Bagher, Amina M. ;
Eid, Basma ;
Almukadi, Haifa ;
Alghamdi, Badrah S. ;
Alahmadi, Ahlam A. ;
Hassan, Nibal A. ;
Sindi, Nariman ;
Alghamdi, Samar A. ;
Almohaimeed, Hailah M. ;
Mohammedsaleh, Zuhair M. ;
Al-Shaikh, Turki M. ;
Almuhayawi, Mohammed S. ;
Ali, Soad S. ;
El-Hamamsy, Manal .
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 :1389-1401
[6]   Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan [J].
Izumo, Takehiro ;
Kuse, Naoyuki ;
Awano, Nobuyasu ;
Tone, Mari ;
Sakamoto, Keita ;
Takada, Kohei ;
Muto, Yutaka ;
Fujimoto, Kazushi ;
Saiki, Ayae ;
Ito, Yu ;
Matsumoto, Haruko ;
Inomata, Minoru .
RESPIRATORY INVESTIGATION, 2021, 59 (05) :635-642
[7]   Determinants of COVID-19 vaccine preference: A survey study in Japan [J].
Kawata, Keisuke ;
Nakabayashi, Masaki .
SSM-POPULATION HEALTH, 2021, 15
[8]   Effects of Vaccination Day Routine Activities on Influenza Vaccine Efficacy and Vaccination-Induced Adverse Reaction Incidence: A Cohort Study [J].
Kenzaka, Tsuneaki ;
Yahata, Shinsuke ;
Goda, Ken ;
Kumabe, Ayako ;
Kamada, Momoka ;
Okayama, Masanobu .
VACCINES, 2021, 9 (07)
[9]   The Xs and Y of immune responses to viral vaccines [J].
Klein, Sabra L. ;
Jedlicka, Anne ;
Pekosz, Andrew .
LANCET INFECTIOUS DISEASES, 2010, 10 (05) :338-349
[10]  
Klimek L, 2021, INTERNIST, V62, P326, DOI 10.1007/s00108-021-00959-5